GlassScriptPhysician profile
Austin S Combs
NPI 1215660683
$2,002.18
in general payments reported to CMS, 2019-2025
24 companies · $1,356 in 2025
The $1,356 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $31.65 · 2024: $614 · 2025: $1,356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922 · Education: $80.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,921.54 |
| Education | $80.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $529.75 | 2024-2025 | Tezspire, Breztri, Fasenra |
| Genzyme Corporation | $262.29 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $237.70 | 2024-2025 | Dupixent |
| Glaxosmithkline, LLC. | $176.19 | 2025 | Nucala, Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $112.92 | 2024-2025 | Glassia |
| Resmed Corp | $102.27 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.92 | 2023-2025 | Ofev, Jardiance |
| Lilly USA, LLC | $64.60 | 2025 | Zepbound |
| Amgen INC. | $53.92 | 2023-2025 | Tezspire |
| Viatris Specialty LLC | $53.60 | 2025 | Yupelri |
| Philips North America LLC | $43.18 | 2025 | Vest Therapy Und |
| Verona Pharma, INC. | $34.88 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $33.72 | 2025 | Tyvaso |
| Harmony Biosciences LLC | $28.88 | 2025 | |
| Insmed, INC. | $27.80 | 2024-2025 | Arikayce |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $25.38 | 2025 | Winrevair |
| Fisher & Paykel Healthcare INC | $24.74 | 2025 | Fisher & Paykel Healthcare |
| Inspire Medical Systems, INC. | $19.41 | 2024 | Inspire |
| Electromed, INC. | $17.91 | 2025 | Smartvest |
| Mylan Specialty L.P. | $16.66 | 2024 | Yupelri |
| Pulmonx Corporation | $16.51 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Itamar Medical INC | $15.96 | 2025 | Watchpatone |
| Paratek Pharmaceuticals, INC. | $15.07 | 2025 | Nuzyra |
| Avadel Cns Pharmaceuticals, LLC | $13.92 | 2025 | Lumryz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Austin Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.